Material Agreement, Asset Transaction, Private Placement, Amendments to Bylaws, Regulation FD Presentation, Management Change/Compensation (Form 8-K)

Alaunos Therapeutics Inc. published this content on October 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 13, 2026 at 13:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]